Molecular cloning of p53 cDNA of Mongolian gerbil and establishment of yeast p53 functional assay system

Helicobacter

Volumn 8, Issue 2, 2003, Pages 81-89

  Ishizuka, Jun ^a   Sugiyama, Toshiro ^a   Aoyama, Tetsuya ^b   Hirayama, Fumihiro ^c   Tada, Mitsuhiro ^b   Kato, Mototsugu ^a   Moriuchi, Tetsuya ^b   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

Functional mutation; Helicobacter pylori; Mongolian gerbil; p53; Yeast functional assay

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GERBIL; HELICOBACTER PYLORI; HOMOLOGOUS RECOMBINATION; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STOMACH CARCINOMA;

ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENETIC VECTORS; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MOLECULAR SEQUENCE DATA; PLASMIDS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

ANIMALIA; GERBILLINAE; HELICOBACTER; HELICOBACTER PYLORI; MERIONES UNGUICULATUS; VECTORS;

EID: 0037278787     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2003.00127.x     Document Type: Article

References (46)

1. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (Phila) 1994;73:2691-4.
2. Nomura A, Stemmermann GN, Chyuou P-H, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
3. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
5. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk to humans, 61; Schistosomes, Liver Flukes and Helicobacter Pylori. Lyon, France: 1994.
6. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 1996;31:755-7.
7. Honda S, Fujioka T, Tokieda M, Gotoh T, Nishizono A, Nasu M. Gastric ulcer, atrophic gastritis and intestinal metaplasia caused by Helicobacter pylori in Mongolian Gerbils. Scand J Gastroenterol 1998;33:454-60.
8. Matsumoto S, Washizuka Y, Matsumoto Y, et al. Induction of ulceration and severe gastritis in Mongolian gerbils by Helicobacter pylori infection. J Med Mocrobiol 1997;46:391-7.
9. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999;34:450-4.
10. Sugiyama A, Maruta F, Ikeno T, et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998;58:2067-9.
11. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
12. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998;58:4255-9.
13. Tokieda M, Honda S, Fujioka T, Nasu M. Effect of Helicobacter pylori infection on the N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in Mongolian gerbils. Carcinogenesis 1999;20:1261-6.
14. Shimizu N, Inada K, Nakanishi H, et al. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999;20:669-76.
15. Tahara E. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Exp Toxicol Pathol 1998;50:375-8.
16. Frohman MA. Rapid amplification of cDNA ends. PCR Primer. A Laboratory Manual. Cold Spring Harbor, MA, USA: Cold Spring Harbor Laboratory Press. 1995:381-409.
17. Ishioka C, Frebourg T, Yan YX, et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 1993;5:124-9.
18. Tada M, Iggo R, Ishii N, et al. Clonality and stability of the p53 gene in human astrocytic tumor cells-quantitative analysis of p53 gene mutations by yeast functional assay. Int J Cancer 1996;67:447-50.
19. Flaman JM, Frebourg T, Moreau V, et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995;92:3963-7.
20. Kashiwazaki H, Tonoki H, Tada M, et al. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 1997;15:2667-74.
21. Stotz A, Linder P. The ADE2 gene from Saccharomyces cerevisiae: sequence and new vectors. Gene 1990;95:91-8.
22. Tada M, Iggo R, Waridel F, et al. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Mol Carcinog. 1997;18:171-6.
23. Tatematsu M, Yamamoto M, Shimizu N, et al. Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N-nitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine in drinking water. Jpn J Cancer Res 1998;89:97-104.
24. Nakatani H, Sakamoto H, Yoshida T, et al. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 1990;81:707-10.
25. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992;50:859-62.
26. Joypaul BV, Newman EL, Hopwood D, et al. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study. J Pathol 1993;170:279-83.
27. Yokozaki H, Kuniyasu H, Kitadai Y, et al. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 1992;119:67-70.
28. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
29. Gomyo Y, Osaki M, Kaibara N, Ito H. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP. Int J Cancer 1996;66:594-9.
30. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992;101:183-9.
31. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
32. Murakami K, Fujioka T, Kodama M, et al. Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J Gastroenterol 2002;37:1-5.
33. Pietenpol J, Tokino T, Thiagalingam S, El-Deiry W, Kinzler K, Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci USA 1994;91:1998-2002.
34. Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15-6.
35. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
36. Jeoung DI, Tang B, Sonenberg M. Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J Biol Chem 1995;270:18367-73.
37. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
38. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-9.
39. Correa P. Human gastric carcinogenesis: a multi-step and multifactorial process - First American cancer. Cancer Res 1992;52:6735-40.
40. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.
41. Tohdo H, Yokozaki H, Haruma K, Kajiyama G, Tahara E. p53 gene mutations in gastric adenomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;63:191-5.
42. Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 1996;69:28-33.
43. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterol 2000;119:7-14.
44. Forbes GM, Warren JR, Glaser ME, Cullen DJE, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after H. pylori eradication. J Gastroenterol Hepatol 1996;11:670-3.
45. Van Der Hulst RWM, Van Der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997;113:25-30.
46. Shimizu N, Ikehara Y, Inada K, et al. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000;60:1512-4.